Ocugen Files 8-K for Operations and Financials
Ticker: OCGN · Form: 8-K · Filed: Apr 2, 2024 · CIK: 1372299
| Field | Detail |
|---|---|
| Company | Ocugen, INC. (OCGN) |
| Form Type | 8-K |
| Filed Date | Apr 2, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations-update
Related Tickers: OCGN
TL;DR
Ocugen filed an 8-K for routine financial and operational updates.
AI Summary
Ocugen, Inc. filed an 8-K on April 2, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The filing does not contain specific financial figures or operational updates beyond the general reporting categories.
Why It Matters
This 8-K filing indicates Ocugen is providing routine updates on its financial status and operational results to the SEC, which is important for investors to monitor the company's health.
Risk Assessment
Risk Level: low — This filing is a standard 8-K for reporting financial condition and results of operations, not indicating any immediate material changes or risks.
Key Players & Entities
- Ocugen, Inc. (company) — Registrant
- April 2, 2024 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of Incorporation
- 11 Great Valley Parkway Malvern, Pennsylvania 19355 (address) — Business Address
- 484-328-4701 (phone_number) — Business Phone
FAQ
What specific financial results are being reported in this 8-K?
The filing indicates it is for 'Results of Operations and Financial Condition' but does not provide specific dollar amounts or detailed financial figures within the provided text.
What is the exact date of the earliest event reported?
The date of the earliest event reported is April 2, 2024.
What is Ocugen, Inc.'s state of incorporation?
Ocugen, Inc. is incorporated in Delaware.
What is the business address of Ocugen, Inc.?
The business address is 11 Great Valley Parkway, Malvern, Pennsylvania 19355.
What is the purpose of this 8-K filing?
The purpose of this 8-K filing is to report on Ocugen, Inc.'s results of operations and financial condition, and to file financial statements and exhibits.
Filing Stats: 632 words · 3 min read · ~2 pages · Grade level 10 · Accepted 2024-04-02 09:25:23
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value per share OCGN The Nasdaq Sto
Filing Documents
- ocgn-20240402.htm (8-K) — 31KB
- ocgn-20240402xex991.htm (EX-99.1) — 20KB
- q4_fy23earningspresentat.htm (EX-99.2) — 4KB
- q4_fy23earningspresentat001.jpg (GRAPHIC) — 52KB
- q4_fy23earningspresentat002.jpg (GRAPHIC) — 191KB
- q4_fy23earningspresentat003.jpg (GRAPHIC) — 88KB
- q4_fy23earningspresentat004.jpg (GRAPHIC) — 78KB
- q4_fy23earningspresentat005.jpg (GRAPHIC) — 110KB
- q4_fy23earningspresentat006.jpg (GRAPHIC) — 118KB
- q4_fy23earningspresentat007.jpg (GRAPHIC) — 37KB
- q4_fy23earningspresentat008.jpg (GRAPHIC) — 122KB
- q4_fy23earningspresentat009.jpg (GRAPHIC) — 40KB
- q4_fy23earningspresentat010.jpg (GRAPHIC) — 120KB
- q4_fy23earningspresentat011.jpg (GRAPHIC) — 33KB
- 0001628280-24-014236.txt ( ) — 1544KB
- ocgn-20240402.xsd (EX-101.SCH) — 2KB
- ocgn-20240402_lab.xml (EX-101.LAB) — 21KB
- ocgn-20240402_pre.xml (EX-101.PRE) — 12KB
- ocgn-20240402_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On April 2, 2024, Ocugen, Inc. (the "Company") issued a press release announcing certain financial data for the fourth quarter and the fiscal year ended December 31, 2023. The Company has scheduled a conference call and webcast for 8:30 a.m. Eastern Time on April 2, 2024, to discuss these financial results and business updates. The Company will use presentation materials in connection with the conference call and webcast, which presentation materials will be posted on the Company's website at www.ocugen.com. Copies of the press release and presentation materials are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K (this "Report") and incorporated herein by reference. The information disclosed under Item 2.02 of this Report, including Exhibit 99.1 an d Exhibit 99.2, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference in any Company filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. The following exhibits are being furnished herewith: (d) Exhibits Exhibit No. Document 99.1 Press Release of Ocugen, Inc. dated April 2 , 202 4 . 99.2 Earnings Release Presentation issued April 2 , 202 4 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 2, 2024 OCUGEN, INC. By: /s/ Shankar Musunuri Name: Shankar Musunuri Title: Chairman, Chief Executive Officer, & Co-Founder 3